These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 29529610

  • 21. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
    Tanaka M, Seki G, Someya T, Nagata M, Fujita T.
    Clin Dev Immunol; 2011; 2011():470803. PubMed ID: 21318178
    [Abstract] [Full Text] [Related]

  • 22. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 23. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
    Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J.
    PLoS One; 2016 Oct; 11(12):e0166830. PubMed ID: 27930655
    [Abstract] [Full Text] [Related]

  • 24. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 25. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 26. IgA nephropathy enigma.
    Mestecky J, Novak J, Moldoveanu Z, Raska M.
    Clin Immunol; 2016 Nov 22; 172():72-77. PubMed ID: 27444044
    [Abstract] [Full Text] [Related]

  • 27. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Nov 22; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
    Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.
    Pediatr Nephrol; 2007 Dec 22; 22(12):2067-72. PubMed ID: 17943324
    [Abstract] [Full Text] [Related]

  • 29. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
    Kolka R, Valdimarsson H, Bodvarsson M, Hardarson S, Jonsson T.
    APMIS; 2013 Sep 22; 121(9):890-7. PubMed ID: 23398317
    [Abstract] [Full Text] [Related]

  • 30. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct 22; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 31. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC, Poon PY, Lai KN.
    J Lab Clin Med; 1999 Feb 22; 133(2):152-60. PubMed ID: 9989767
    [Abstract] [Full Text] [Related]

  • 32. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J.
    J Autoimmun; 2021 Mar 22; 118():102593. PubMed ID: 33508637
    [Abstract] [Full Text] [Related]

  • 33. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Mar 22; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 34. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar 22; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 35. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.
    Kidney Int; 2007 Jun 22; 71(11):1148-54. PubMed ID: 17342176
    [Abstract] [Full Text] [Related]

  • 36. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 37. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec 11; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 38. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Dec 11; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 39. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar 11; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 40. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep 11; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.